Journal of Medicinal Chemistry p. 1086 - 1097 (2018)
Update date:2022-08-04
Topics:
Piotrowski, David W.
Futatsugi, Kentaro
Casimiro-Garcia, Agustin
Wei, Liuqing
Sammons, Matthew F.
Herr, Michael
Jiao, Wenhua
Lavergne, Sophie Y.
Coffey, Steven B.
Wright, Stephen W.
Song, Kun
Loria, Paula M.
Banker, Mary Ellen
Petersen, Donna N.
Bauman, Jonathan
A novel series of morpholine-based nonsteroidal mineralocorticoid receptor antagonists is reported. Starting from a pyrrolidine HTS hit 9 that possessed modest potency but excellect selectivity versus related nuclear hormone receptors, a series of libraries led to identification of morpholine lead 10. After further optimization, cis disubstituted morpholine 22 was discovered, which showed a 45-fold boost in binding affinity and corresponding functional potency compared to 13. While 22 had high clearance in rat, it provided sufficient exposure at high doses to favorably assess in vivo efficacy (increased urinary Na+/K+ ratio) and safety. In contrast to rat, the dog and human MetID and PK profiles of 22 were adequate, suggesting that it could be suitable as a potential clinical asset.
View MoreShandong Yuanli Science and Technology Co., Ltd.
Contact:86-0536-6777557
Address:Zhuliu Industiral Park,Changle County
Hefei TNJ chemical industry co.,ltd
website:https://www.tnjchem.com
Contact:+86-551-65418695
Address:B911 Xincheng Business Center, Qianshan Road, Hefei Anhui China
Tianjin Derchemist Sci-Tech Co., Ltd.
website:http://www.derchemist.com
Contact:+86-22-58627059
Address:Xinmao Science and Technology Park,Huayuan Industrial Park
Contact:
Address:
Daqing E-shine Chemical Co.,LTD
Contact:0086-024-31285112
Address:Hongweiyuan area, Ranghulu district
Doi:10.1016/0022-328X(91)86057-W
(1991)Doi:10.1039/c2ob06942c
(2012)Doi:10.1016/0022-328X(91)80062-O
(1991)Doi:10.1016/j.poly.2012.02.024
(2012)Doi:10.1002/anie.201109130
(2012)Doi:10.1007/s10600-012-0212-6
(2012)